The COVID-19 Pandemic – News and Features
FDA Issues Guidance for Conducting Clinical Trials During Coronavirus Pandemic
The U.S. Food and Drug Administration (FDA) has issued guidance for industry, investigators and institutional review boards conducting clinical trials during the novel coronavirus (COVID-19) pandemic.
CloudLIMS Offers Free LIMS to SARS-CoV-2 and COVID-19 Research and Testing Laboratories
CloudLIMS is making its "in the cloud" LIMS free of charge to any research facility or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of the world.
How Are Government Recommendations on COVID-19 Measures Being Received?
To capture public sentiment towards government recommendations, a YouGov survey was commissioned and completed by 2,108 UK adults between the dates of 17th – 18th March 2020. Here's what the public think.
Portal for Sharing Data From Coronavirus Trials Set To Launch
Vivli, the Center for Clinical Research Data, is launching a COVID-19 portal for sharing of completed interventional treatment trial data.
FDA Issues First Emergency Use Authorization for COVID-19 Point of Care Diagnostic
The FDA has issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test.
Coronavirus – Only Mission-critical Functions Within NIH Labs Will Be Supported To Reduce Risk of Transmission
To further reduce the risk of transmission of COVID-19 and for the safety of staff, the National Institutes of Health (NIH) is shifting all non-mission-critical laboratory operations to a maintenance phase.
Antibody To Treat Lung Inflammation May Offer Potential in COVID-19
Early stage biotech company Aqualung Therapeutics is currently developing a therapeutic monoclonal antibody – ALT-100 – for the treatment of unchecked inflammation. COVID-19 can cause severe pneumonia and respiratory failure. There is therefore a potential option to treat patients diagnosed with COVID-19 with ALT-100. Technology Networks recently spoke with Joe Garcia, MD, Founder and Chief Executive Officer of Aqualung Therapeutics to learn more.
Development of Immunotherapy To Treat COVID-19 in Progress
CEL-SCI Corporation recently announced that it is utilizing LEAPS peptide technology in efforts to develop an immunotherapy against the novel coronavirus caused by SARS-CoV-2. Technology Networks, spoke with Daniel Zimmerman, Ph.D. Senior VP of Research, Cellular Immunology at CEL-SCI Corporation, to learn more about the LEAPS technology.
How COVID-19 May Impact Farming
Researchers from the University of Wisconsin Madison discuss the potential impacts of COVID-19 on the agricultural industry.
AI Device Can Track Virus Trends by Listening for Coughing
University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning - called FluSense - which can detect coughing and crowd size in real time, then analyze the data to directly monitor flu-like illnesses and influenza trends.